• Do you have Asthma?
You may qualify to participate in a research study if you:

-Are between 18-75 years of age
-Self identify as African American or Black
-Take inhaled corticosteroid medications such as Flovent, QVAR, Pulmicort, Symbicort®, Advair® or Dulera

African Americans suffer a disproportionate burden of asthma morbidity compared to the general population, along with more asthma-related urgent care visits and higher rates of hospitalizations. This research study is being done to test if taking inhaled corticosteroids at different doses with or without long acting beta agonist (LABA) will help prevent worsening asthma symptoms and asthma attacks. Each participant will receive four study treatments across four treatment periods lasting 14 weeks each. The order in which the treatments will be received will be determined randomly. Participants will receive up to $1,000 in compensation. For more information, please contact:

[Asthma Research Center, 1-888-99-ASTHMA or ARC@Partners.Org]
Institution  –  BWH - Brigham and Women's Hospital, Boston, MA
Principal Investigator  – Elliot Israel
Enrollment Information
For further information about enrolling a patient in this trial, contact the person below.
Name  – Brendan Allison
Phone  – 617-732-8201